Catalyst Calendar - March 26, 2026 (EOD)

 ## Today's Catalyst Results How did scheduled events play out? - **Adobe (ADBE)** - William Blair downgraded the stock rating citing increased competition concerns. Despite this, shares rose 1.17% to $240.02, suggesting some investor resilience or offsetting factors. - **Chewy (CHWY)** - Citizens lowered the price target on valuation grounds but maintained a buy rating. Shares gained 1.66% to $27.01, reflecting positive market reception to the cautious optimism. - **Kalvista Pharmaceuticals (data not available)** - Citizens cut the price target due to a steady launch, indicating tempered expectations. - **Shift4 Payments (data not available)** - Raymond James downgraded the stock on growth concerns, signaling caution in the payments sector. - **Global Payments (data not available)** - Raymond James also downgraded this stock on valuation concerns, adding pressure on payment processors. - **Fiserv (data not available)** - Raymond James downgraded on growth concerns, consistent with the sector's cautious tone. - **DigitalOcean (data not available)** - Citizens raised the price target to $105 citing funding strength, a bullish signal for cloud infrastructure. - **H&M** - Reported sales falling short of expectations, contributing to broader concerns about retail demand. - **Ares Management (APO, ARES)** - Private credit fund posted its worst monthly loss on record, highlighting stress in private credit markets. - **US Stock Futures** - Slipped amid uncertainty over Middle East war de-escalation, reflecting geopolitical risk weighing on sentiment. ## Surprise News Today Unexpected developments that moved markets: - **Journey Medical Corporation (DERM)** - Shares plunged 28.84% to $4.86 after missing earnings and revenue estimates, signaling investor disappointment. - **Dyadic International (DYAI)** - Fell 19.63% to $0.70 following earnings miss and revenue shortfall, underscoring challenges in biotech. - **Navan, Inc. (NAVN)** - Surged 47.10% to $13.46 on strong Q4 2026 earnings results, a significant positive surprise. - **Beam Therapeutics (BEAM)** - Rose 2.59% to $23.72 after discussing promising Phase I/II data for BEAM-302 in Alpha-1 Antitrypsin Deficiency, boosting biotech sentiment. - **SoFi (SOFI)** - Declined 3.62% to $15.96 amid increased short seller activity, raising concerns about the fintech’s near-term outlook. - **Meta Platforms (META)** - Dropped sharply 7.52% to $550.17 on broad tech sell-off and ongoing valuation pressure. - **Micron Technology (MU)** - Declined 6.57% to $357.00 after a rating downgrade citing softness in DRAM orders, reflecting semiconductor demand worries. - **Nvidia (NVDA)** - Fell 3.63% to $172.20 despite ongoing AI optimism, pressured by broader tech weakness. - **Amazon (AMZN)** - Declined 1.71% to $208.10 following news of AI chip product leader departure, raising questions about AI hardware execution. ## After-Hours Catalysts Earnings and events happening tonight: - **Navan, Inc. (NAVN)** - Investors will watch for further details on Q4 2026 earnings after a strong market reaction today. - **Journey Medical Corporation (DERM)** - Market will digest the full earnings call and outlook following the sharp stock decline. - **Dyadic International (DYAI)** - Earnings call transcript release may provide clarity on operational challenges. - **Beam Therapeutics (BEAM)** - Further updates on clinical trial progress and pipeline potential expected. - **THG Holdings (THG)** - FY25 results and outlook to be reviewed for signs of recovery momentum. - **Cryoport (CYRX)** - Q4 2025 earnings call to clarify revenue beat despite EPS miss. - **Syndax Pharmaceuticals (data not available)** - Q4 2025 revenue beat may influence biotech sector sentiment. ## Tomorrow's Calendar Key events scheduled for tomorrow: - **Morgan Stanley Equity Residential** - Watch for earnings report and commentary on market resilience. - **Morgan Stanley AvalonBay Communities** - Earnings outlook to be monitored following recent downgrade. - **Jefferies Robinhood (HOOD)** - Initiation with buy rating on product growth to be closely followed. - **JPMorgan Casey’s General Stores and Murphy USA** - New coverage initiations with ratings to provide sector insights. - **JPMorgan Scotts Miracle-Gro** - Downgrade on raw material costs to be evaluated in earnings context. - **UBS Mosaic and Nutrien** - Downgrades on margin and pricing concerns may impact materials sector. - **Hensoldt AG** - FY25 earnings and tax impact to be reviewed. - **Kingfisher plc** - Q4 2026 earnings call transcript expected to provide retail sector updates. ## This Week Ahead Other catalysts coming this week: - **May 14-15**: Trump-Xi Summit in Beijing, a key geopolitical event with potential market impact. - **April**: European Central Bank’s Nagel signals rate hike option, important for fixed income and currency markets. ## Highest Conviction Setup Based on today's action and upcoming catalysts: - Stock: **$NAVN** (Navan, Inc.) - Catalyst: Strong Q4 2026 earnings surprise and positive market reaction - Thesis: Navan’s significant earnings beat and 47.10% stock surge indicate robust growth momentum and investor confidence. The after-hours earnings call will be critical to confirm sustainability, making it a high-conviction trade ahead of further earnings detail. --- Overall, the market faced pressure from geopolitical uncertainty and tech sector downgrades, with the S&P 500 down 1.40% and Nasdaq 100 down 2.03%. Energy stocks like **$VLO** and **$CVX** outperformed amid rising oil prices, while defensive names and select biotech showed resilience. Investors should monitor tomorrow’s earnings and geopolitical developments closely for directional cues.